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Abstract
High levels of serum IgE are considered markers of parasite and helminth exposure. In addition, they are associated with
allergic disorders, play a key role in anti-tumoral defence, and are crucial mediators of autoimmune diseases. Total IgE is a
strongly heritable trait. In a genome-wide association study (GWAS), we tested 353,569 SNPs for association with serum IgE
levels in 1,530 individuals from the population-based KORA S3/F3 study. Replication was performed in four independent
population-based study samples (total n=9,769 individuals). Functional variants in the gene encoding the alpha chain of
the high affinity receptor for IgE (FCER1A) on chromosome 1q23 (rs2251746 and rs2427837) were strongly associated with
total IgE levels in all cohorts with P values of 1.85610
220 and 7.08610
219 in a combined analysis, and in a post-hoc analysis
showed additional associations with allergic sensitization (P=7.78610
24 and P=1.95610
23). The ‘‘top’’ SNP significantly
influenced the cell surface expression of FCER1A on basophils, and genome-wide expression profiles indicated an
interesting novel regulatory mechanism of FCER1A expression via GATA-2. Polymorphisms within the RAD50 gene on
chromosome 5q31 were consistently associated with IgE levels (P values 6.28610
2724.46610
28) and increased the risk for
atopic eczema and asthma. Furthermore, STAT6 was confirmed as susceptibility locus modulating IgE levels. In this first
GWAS on total IgE FCER1A was identified and replicated as new susceptibility locus at which common genetic variation
influences serum IgE levels. In addition, variants within the RAD50 gene might represent additional factors within cytokine
gene cluster on chromosome 5q31, emphasizing the need for further investigations in this intriguing region. Our data
furthermore confirm association of STAT6 variation with serum IgE levels.
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High levels of IgE have been considered for many years as
markers of parasite and helminth exposure to which they confer
resistance [1]. In Western lifestyle countries with less contact,
however, elevated IgE levels are associated with allergic disorders
[2]. Only recently, it has been established that IgE antibodies also
play a key role in anti-tumoral defence [3] and are crucial
mediators of autoimmune diseases [4], thus challenging the
traditional Th1/Th2 dogma.
High total serum IgE levels are closely correlated with the
clinical expression and severity of asthma and allergy [5,6]. The
regulation of serum IgE production is largely influenced by
familial determinants, and both pedigree- and twin-based studies
provided evidence of a strong genetic contribution to the
variability of total IgE levels [7,8]. Genetic susceptibility of IgE-
responsiveness is likely to be caused by a pattern of polymorphisms
in multiple genes regulating immunologic responses[9], but so far
only very few loci could be established consistently and robustly,
most notable FCER1B, IL-13 and STAT6 [10,11].
Family and case-control studies indicated that total serum IgE
levels are largely determined by genetic factors that are
independent of specific IgE responses and that total serum IgE
levels are under stronger genetic control than atopic disease
[8,12,13,14]. An understanding of the genetic mechanisms
regulating total serum IgE levels might also aid in the dissection
of the genetic basis of atopic diseases. In an attempt to identify
novel genetic variants that affect total IgE levels, we conducted a
genome-wide association study (GWAS) in 1,530 German adults
and replicated the top signals in altogether 9,769 samples of four
independent study populations.
Results
Genome-wide Association Scan
For the GWAS 1,530 individuals from the population-based
KORA S3/F3 500 K study with available total IgE levels were
typed with the Affymetrix 500 K Array Set. For statistical analysis,
we selected SNPs by including only high-quality genotypes to
reduce the number of false positive signals. A total of 353,569
SNPs passed all quality control measures and were tested for
associations with IgE levels. Figure 1 summarizes the results of the
KORA S3/F3 500 K analysis. No single SNPs reached genome-
wide significance, but the scan pointed to the gene encoding the
alpha chain of the high affinity receptor for IgE (FCER1A)o n
chromosome 1 (Figure 1A). Particularly the quantile-quantile-plot
of the P values illustrates observed significant associations beyond
those expected by chance (Figure 1B).
Replication and Fine-Mapping
For replication in the independent population-based KORA S4
cohort (N=3,890), we used the following inclusion criteria: (i)
P,10
24 in the genome wide analysis (39 SNPs, 35 expected); (ii)
P,10
23 with at least one neighboring SNPs (6100 kb) with
P,10
23 (45 SNPs). The specific results for all SNPs in the GWAS
and KORA S4 are given in supplementary table S3. Six SNPs were
significantly associated with total IgE levels in KORA S4 with P
values ranging from 2.47610
24 to 3.23610
29 (given a Bonferroni-
correctedsignificancelevelof5.10610
24).Thestrongestassociations
were observed for rs2427837 (P=3.23610
29), which is located in
the 59 region of FCER1A, and rs12368672 (P=2.03610
26), which is
located in the 59 region of STAT6. In addition, all 4 RAD50 SNPs
which had been selected in the GWAS could be replicated.
Effect estimates of the SNPs in FCER1A and STAT6 were only
slightly lower compared to those in the KORA S3/F3 500 K
Figure 1. Results of the KORA S3/F3 500 K analysis. a) Genome-
wide association study of chromosomal loci for IgE levels: the analysis is
based on a population-based sample of 1530 persons. The x-axis
represents the genomic position of 353,569 SNPs, and the y-axis shows
2log10 (P value). b) Quantile-quantile plot of P values: Each black dot
represents an observed statistic (defined as the 2log10( P value)) versus
the corresponding expected statistic. The line corresponds to the null
distribution.
doi:10.1371/journal.pgen.1000166.g001
Author Summary
High levels of serum IgE are considered markers of parasite
and helminth exposure. In addition, they are associated
with allergic disorders, play a key role in anti-tumoral
defence, and are crucial mediators of autoimmune
diseases. There is strong evidence that the regulation of
serum IgE levels is under a strong genetic control.
However, despite numerous loci and candidate genes
linked and associated with atopy-related traits, very few
have been associated consistently with total IgE. This study
describes the first large-scale, genome-wide scan on total
IgE. By examining .11,000 German individuals from four
independent population-based cohorts, we show that
functional variants in the gene encoding the alpha chain of
the high affinity receptor for IgE (FCER1A) on chromosome
1q23 are strongly associated with total IgE levels. In
addition, our data confirm association of STAT6 variation
with serum IgE levels, and suggest that variants within the
RAD50 gene might represent additional factors within
cytokine gene cluster on chromosome 5q31, emphasizing
the need for further investigations in this intriguing region.
Genome-Wide Association Study on Total IgE
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RAD50. The rare allele ‘‘G’’ of the top ranked SNP rs2427837 in
FCER1A had an estimated effect per copy of 20.212 based on the
logarithm of total IgE. This translates into an estimated decrease
of 19.1% in total serum IgE level for the heterozygote genotype
and 34.6% for the rare homozygote genotype, which was
significantly associated with an increased FCER1A expression
on IgE-stripped basophils (Figure 2).
The estimated effect of the STAT6 SNP rs12368672 was 0.156
resulting in an increase of total IgE of 16.9% and 36.6% for the
heterozygote and rare homozygote genotype, respectively. The
most significant SNP in the RAD50 gene (rs2706347) had an effect
estimate of 0.143 (P=2.26610
24) with an associated increase in
total IgE of 15.4% and 33.1%. Altogether the variance of total IgE
level explained by genotypes of the three replicated regions was
about 1.9%.
To fine-map the regions of strong association in greater detail,
we selected additional SNPs covering the FCER1A and RAD50
gene region based on HapMap data from individuals of European
ancestry. In addition, two previously described promoter SNPs of
FCER1A (rs2251746, rs2427827) [15,16], as well as 2 SNPs in the
RAD50 hypersensitive site 7 (RHS7) in intron 24 (rs2240032,
rs2214370)[17] were included. In total, 14 SNPs were genotyped
in KORA S4. We found the strongest association in the proximal
promoter region of the FCER1A gene, at rs2251746, which was in
strong LD (r
2=0.96) with rs2427837 (Table 1 and Figure 3). The
contribution of the two alleles of rs2251746 in homozygotes and
heterozygotes is given in Figure S1. Their effect is observed across
the full range of IgE values. The strongest observed association of
SNP rs2251746 and the distribution of the SNPs in the region are
shown in Figure 3A. None of the RAD50 SNPs in the fine-mapping
showed distinctly stronger association with total IgE (Figure 3B).
We additionally sequenced all FCER1A exons with adjacent
intronic sequences in 48 male and 48 female samples selected
equally from the extremes of the serum IgE distribution in 3,890
individuals from the KORA S4 cohort. We identified two new
mutations, each present in one individual only, and concurrently
confirmed three SNPs already annotated in public databases
(dbSNP) with validated minor allele frequencies in Europeans.
None of the novel mutations were predicted to have functional
consequences (for details see Text S1 and Tables S5 and S6).
Haplotype analysis for the FCER1A gene showed lower total IgE
levels with effect estimates ranging from 20.18 to 20.32 for a
haplotype described by the rare ‘‘G’’ allele of rs2427837 and the
rare ‘‘C’’ allele of rs2251746 (haplotype frequency 26.4%) in
comparison to all other common haplotypes carrying both major
alleles (Table S7).
For further replication of the KORA S4 results in the
population-based children cohorts GINI (n=1,839), LISA
(n=1,042) and ISAAC (n=2,998) the top 6 SNPs: rs2251746,
rs2427837, rs2040704, rs2706347, rs3798135, rs7737470 and
rs12368672 were tested for association with total serum IgE levels.
In GINI, all SNPs except rs12368672 yielded significant P values
ranging from 0.029 to 8.14610
26. After correction for multiple
testing SNP rs2706347 is slightly above the significance level. In
LISA, the two FCER1A polymorphisms rs2251746 and rs2427837
were strongly associated (P=4.18610
25 and 6.58610
25), while
the RAD50 SNPs showed consistent trends, but no statistical
significance. In ISAAC, the effect estimates of the two FCER1A
SNPs were distinctly smaller than in the other replication samples
but in the same direction and significantly associated with P values
of 2.11610
24 for rs2251746 and of 4.27610
24 for rs2427837.
The RAD50 SNPs showed effect estimates in concordance with the
other replication samples but were only borderline significant.
Additional analysis of markers in the RAD50-IL13 region in a
subset of 526 children from the ISAAC replication cohort (for
details see Table S9) indicated presence of one linkage
disequilibrium (LD) block, which encompasses the entire RAD50
gene and extends into the promoter region of the IL13 gene,
whereas rs20541 showed low levels of LD with RAD50 variants
(r2,0.3) (Figure S2)
In the combined analysis of all replication samples both selected
FCER1A SNPs (P=1.85610
220 and 7.08610
219 for rs2251746 and
rs2427837, respectively) and RAD50 SNPs (P=6.28 610
272
4.46610
28) were significantly associated with IgE levels. Effect
estimates were consistent throughout all replication cohorts.
Association Analysis with Dichotomous Traits
In a post hoc analysis of the KORA S4 and ISAAC replication
cohorts, FCER1A polymorphisms rs2251746 and rs2427837
showed association with allergic sensitization (P=7.78610
24
and 1.95610
23 in KORA, P=0.025 and 0.032 in ISAAC), while
there were no significant associations for the dichotomous traits
asthma, rhinitis and atopic eczema (AE). However, the number of
cases for these traits was relatively low. We therefore additionally
typed a cohort of 562 parent-offspring trios for AE from Germany
and a population of 638 asthma cases and 633 controls from UK.
In these cohorts we observed weak associations of RAD50 variants
with eczema (P=0.007–0.01) and with asthma (P=0.017–0.002,
Table S8).
Discussion
In this large-scale population-based GWAS with follow-up
investigations in 9,769 individuals from 4 independent population-
based study samples we show that functional variants of the gene
encoding the alpha chain of the high affinity receptor for IgE
(FCER1A) are of major importance for the regulation of IgE levels.
The high affinity receptor for IgE represents the central
receptor of IgE-induced type I hypersensitivity reactions such as
the liberation of vasoactive mediators including serotonin and
Figure 2. Expression of the FCER1 alpha chain on IgE-stripped
basophils. PBMCs were isolated from individuals displaying high sIgE
levels and FCER1 alpha chain expression was measured after stripping
IgE from its receptor by lactic acid buffer incubation by FACS. Results
are expressed as mean fluorescence intensity for FCER1A in the
basophile gate. Significance was calculated using the Student’s-t-test.
doi:10.1371/journal.pgen.1000166.g002
Genome-Wide Association Study on Total IgE
PLoS Genetics | www.plosgenetics.org 3 August 2008 | Volume 4 | Issue 8 | e1000166T
a
b
l
e
1
.
A
s
s
o
c
i
a
t
i
o
n
b
e
t
w
e
e
n
t
o
t
a
l
I
g
E
a
n
d
s
e
l
e
c
t
e
d
S
N
P
s
i
n
t
h
e
G
W
A
S
s
a
m
p
l
e
a
n
d
i
n
t
h
e
f
o
u
r
r
e
p
l
i
c
a
t
i
o
n
s
a
m
p
l
e
s
.
G
W
A
S
K
O
R
A
S
3
/
F
3
R
e
p
l
i
c
a
t
i
o
n
K
O
R
A
S
4
R
e
p
l
i
c
a
t
i
o
n
G
I
N
I
R
e
p
l
i
c
a
t
i
o
n
L
I
S
A
R
e
p
l
i
c
a
t
i
o
n
I
S
A
A
C
C
o
m
b
i
n
e
d
n
=
1
,
5
3
0
n
=
3
,
8
9
0
n
=
1
,
8
3
9
n
=
1
,
0
4
2
n
=
2
,
9
9
8
n
=
9
,
7
6
9
G
e
n
e
S
N
P
E
s
t
.
P
v
a
l
u
e
E
s
t
.
%
E
s
t
.
P
v
a
l
u
e
E
s
t
.
%
E
s
t
.
P
v
a
l
u
e
E
s
t
.
%
E
s
t
.
P
v
a
l
u
e
E
s
t
.
%
E
s
t
.
P
v
a
l
u
e
E
s
t
.
%
E
s
t
.
P
v
a
l
u
e
E
s
t
.
%
F
C
E
R
1
A
r
s
2
5
1
1
2
1
1
2
0
.
2
0
6
9
.
2
8
E
-
0
8
2
1
8
.
5
9
F
C
E
R
1
A
r
s
1
0
4
8
9
8
5
4
0
.
1
5
3
2
.
8
5
E
-
0
2
1
6
.
5
2
F
C
E
R
1
A
r
s
2
4
9
4
2
6
2
0
.
1
2
2
1
.
6
7
E
-
0
4
1
2
.
9
9
F
C
E
R
1
A
r
s
2
4
2
7
8
3
7
2
0
.
2
3
5
6
.
1
9
E
-
0
5
2
2
0
.
9
4
2
0
.
2
1
2
3
.
2
3
E
-
0
9
2
1
9
.
1
2
2
0
.
2
1
9
2
.
5
1
E
-
0
5
2
1
9
.
6
4
2
0
.
2
8
0
6
.
5
8
E
-
0
5
2
2
4
.
5
6
2
0
.
1
4
5
4
.
2
7
E
-
0
4
2
1
3
.
5
3
2
0
.
2
0
2
7
.
0
8
E
-
1
9
2
1
8
.
2
7
F
C
E
R
1
A
r
s
1
2
5
6
5
7
7
5
0
.
1
1
9
2
.
4
5
E
-
0
2
1
2
.
5
6
F
C
E
R
1
A
r
s
2
4
2
7
8
2
4
0
.
0
8
2
2
.
5
2
E
-
0
2
8
.
4
9
F
C
E
R
1
A
r
s
3
8
4
5
6
2
5
0
.
0
8
5
5
.
0
9
E
-
0
2
8
.
8
2
F
C
E
R
1
A
r
s
2
4
2
7
8
2
7
0
.
1
2
0
2
.
4
5
E
-
0
4
1
2
.
7
2
F
C
E
R
1
A
r
s
2
2
5
1
7
4
6
2
0
.
2
2
7
6
.
0
7
E
-
1
0
2
2
0
.
2
9
2
0
.
2
3
6
8
.
1
4
E
-
0
6
2
2
0
.
9
9
2
0
.
2
9
0
4
.
1
8
E
-
0
5
2
2
5
.
1
7
2
0
.
1
5
3
2
.
1
1
E
-
0
4
2
1
4
.
1
6
2
0
.
2
1
3
1
.
8
5
E
-
2
0
2
1
9
.
2
1
R
A
D
5
0
r
s
2
0
6
9
8
1
2
2
0
.
0
5
2
1
.
4
2
E
-
0
1
2
4
.
9
8
R
A
D
5
0
r
s
2
7
0
6
3
4
7
0
.
2
3
6
4
.
0
5
E
-
0
5
2
6
.
6
2
0
.
1
4
3
2
.
2
6
E
-
0
4
1
5
.
4
3
0
.
1
2
2
2
.
9
1
E
-
0
2
1
3
.
0
2
0
.
1
1
8
1
.
0
1
E
-
0
1
1
2
.
5
6
0
.
0
9
5
2
.
7
0
E
-
0
2
9
.
9
6
0
.
1
2
0
6
.
2
8
E
-
0
7
1
2
.
8
0
R
A
D
5
0
r
s
6
8
8
4
7
6
2
0
.
0
3
4
7
.
2
2
E
-
0
1
3
.
4
6
R
A
D
5
0
r
s
1
7
7
7
2
5
6
5
2
0
.
0
9
6
2
.
2
7
E
-
0
1
2
9
.
1
7
R
A
D
5
0
r
s
1
7
7
7
2
5
8
3
2
0
.
0
5
8
1
.
2
4
E
-
0
1
2
5
.
6
2
R
A
D
5
0
r
s
3
7
9
8
1
3
5
0
.
2
2
7
6
.
5
8
E
-
0
5
2
5
.
4
8
0
.
1
4
2
2
.
3
2
E
-
0
4
1
5
.
2
0
0
.
1
7
3
2
.
0
0
E
-
0
3
1
8
.
9
1
0
.
1
0
7
1
.
3
7
E
-
0
1
1
1
.
2
6
0
.
1
0
1
1
.
7
5
E
-
0
2
1
0
.
6
4
0
.
1
2
9
6
.
6
9
E
-
0
8
1
3
.
8
2
R
A
D
5
0
r
s
2
0
4
0
7
0
4
0
.
2
2
1
9
.
2
5
E
-
0
5
2
4
.
7
3
0
.
1
4
0
2
.
4
7
E
-
0
4
1
4
.
9
7
0
.
1
5
8
4
.
4
0
E
-
0
3
1
7
.
1
4
0
.
1
1
1
1
.
2
1
E
-
0
1
1
1
.
7
3
0
.
1
1
2
8
.
2
2
E
-
0
3
1
1
.
8
3
0
.
1
3
0
4
.
4
6
E
-
0
8
1
3
.
9
0
R
A
D
5
0
r
s
7
7
3
7
4
7
0
0
.
2
3
1
4
.
8
1
E
-
0
5
2
5
.
9
9
0
.
1
4
2
2
.
2
7
E
-
0
4
1
5
.
2
8
0
.
1
6
3
3
.
7
0
E
-
0
3
1
7
.
7
0
0
.
1
0
0
1
.
6
4
E
-
0
1
1
0
.
5
5
0
.
0
8
7
4
.
1
3
E
-
0
2
9
.
1
2
0
.
1
2
3
3
.
3
5
E
-
0
7
1
3
.
0
7
R
A
D
5
0
r
s
2
2
4
0
0
3
2
0
.
1
3
7
4
.
0
1
E
-
0
4
1
4
.
6
7
R
A
D
5
0
r
s
2
2
1
4
3
7
0
0
.
1
3
6
5
.
9
5
E
-
0
1
1
4
.
5
4
S
T
A
T
6
r
s
1
2
3
6
8
6
7
2
0
.
1
6
7
8
.
5
2
E
-
0
4
1
8
.
1
8
0
.
1
5
6
2
.
0
3
E
-
0
6
1
6
.
9
3
0
.
0
1
6
7
.
3
4
E
-
0
1
1
.
6
5
0
.
0
7
5
2
.
4
4
E
-
0
1
7
.
7
8
0
.
1
0
8
1
.
5
2
E
-
0
5
1
1
.
4
4
d
o
i
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
g
e
n
.
1
0
0
0
1
6
6
.
t
0
0
1
Genome-Wide Association Study on Total IgE
PLoS Genetics | www.plosgenetics.org 4 August 2008 | Volume 4 | Issue 8 | e1000166histamine, but also for the induction of profound immune
responses through the activation of NFkappa B and downstream
genes [18]. It is usually expressed as a abc2 complex on mast cells
and basophils, but additionally as a ac2 complex on antigen-
presenting cells (APCs) as shown for dendritic cells and monocytes
[18]. Interestingly, in APCs, IgE-recognition of allergens also leads
to facilitated allergen uptake via FCER1 and thereby contributes
to a preferential activation of Th2-subsets of T-cells. Its expression
is substantially influenced by the binding of IgE to either form of
the receptor as bound IgE apparently protects the receptor from
degradation and thus enhances surface expression without de novo
protein synthesis. Of note, binding of IgE in the two different
complexes only uses the alpha subunit of the receptor lacking
contact sites with the beta or gamma subunits. Consequently, the
expression level of the alpha subunit is crucial for IgE levels on
immune cells [18].
Previous studies suggested linkage of atopy to the gene encoding
the b chain of the high-affinity IgE receptor (FCRER1B) [19].
FCER1B plays a critical role in regulating the cellular response to
IgE and antigen through its capacity to amplify FCER1 signalling
and regulate cell-surface expression [18], and there have been
several studies which reported an association of FCER1B variants
and atopy-related traits but conflicting results for total IgE
[20,21,22,23,24,25,26,27,28]. In a more recent study, no associ-
ation between FCER1B tagSNPs and IgE levels was observed [22].
The 500 k random SNP array contained only one SNP within as
well as 31 SNPs within a 100-kb region around this gene, which
were not significantly associated with total IgE. However, we
cannot rule out that we missed relevant variants in this gene.
In the present study we identified FCER1A as susceptibility locus
in a genome-wide association scan and replicated association of
the FCER1A polymorphism rs2427837 with serum IgE levels in a
total of 9,769 individuals from 4 independent population-based
cohorts with a combined P value of 7.08610
219. This SNP is in
complete LD with the FCER1A polymorphism rs2251746, for
which we observed a combined P value of 1.85610
220.
Besides the continuous cycling of the IgE receptor subunits from
intracellular storage pools to the surface, there is also a substantial
expression of the alpha subunit after stimulation with IL-4 which
requires de novo protein synthesis [18]. This induction is stimulated
by the transcription factor GATA-1, which has a binding site in
the putative promoter region of the FCER1A gene. Notably, in a
previous study with Japanese individuals it could be shown that the
minor allele of the polymorphism rs2251746 is associated with
higher FCER1A expression through enhanced GATA-1 binding
[15]. In line with this we observed an increased cell surface
expression of FCER1A on IgE-stripped basophils from individuals
homozygous for the ‘‘G’’ allele at rs2427837 (Figure 2). Analysis of
Figure 3. P value and pairwise linkage disequilibrium diagram of the region on chromosome 1q23, area of FCER1A (panel A), and
chromosome 5q31, area of RAD50 (panel B). Pairwise LD, measured as D’, was calculated from KORA S3/F3 500 K. Shading represents the
magnitude of pairwise LD with a white to red gradient reflecting lower to higher D’ values. Gene regions are indicated by colored bars. P value
diagram: The x-axis represents the genomic position. The y-axis shows 2log10 (P values) of KORA S3/F3 500 K (blue), KORA S4 (black), GINI (yellow),
LISA (green), ISAAC (orange), combined replication samples (red).
doi:10.1371/journal.pgen.1000166.g003
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KORAsamples wherewhole genomeblood expression profiles were
available revealed no significant effect. However, FCER1A
expression showed a significant dependency on IL-4 (P=0.0087)
and GATA-1 expression (P=1.4 610
24), confirming the known
stimulation pathway. Interestingly, we found a highly significant
dependency of FCER1A expression on GATA-2 transcript levels
(p=7.8610
227). While whole blood expression levels could easily
obscure the situation in basophils, this finding might indicate a novel
regulatory mechanisms of FCER1A expression via GATA-2 [18].
The large (.50 kb) RAD50 gene, which encodes an ubiquitously
expressed DNA repair protein, is located within the Th2-cytokine
locus on chromosome 5q31, which has been linked with total IgE
[29]. It contains multiple conserved non-coding sequences with
presumed regulatory function [30]. Remarkably, evidence has
been provided for the presence of a locus control region (LCR)
within a 25 kb segment of the 39 region of this gene, which plays
an important role in the regulation of Th2 cytokine gene
transcription [31]. The core of this LCR is constituted by four
RAD50 hypersensitive sites (RHS) in intron 21 (RHS4-6) and 24
(RHS7) [17,32,33]. The finding of an association between RAD50
variants and IgE levels is new and biologically compelling.
However, it has to be considered that so far RAD50 has not
emerged as candidate, but that several known candidate genes for
atopy-related traits map to this region with strong linkage
disequlibrium, especially IL13, which is one of the strongest and
widely replicated candidate genes [10,11]. Notably, two functional
IL13 polymorphisms, IL13-1112CT (rs1800925) in the promoter
region and IL13+2044GA (IL13 Arg130Gln, rs20541) in Exon 4,
have been shown to be associated with a range of atopy-related
disorders. IL13+2044GA (rs20541) did not pass our selection
criteria, and IL13-1112CT (rs1800925) is not contained in the
Affymetrix 500 K Array Set. Additional analysis of markers in this
region including these two SNPs showed one LD block
encompassing the entire RAD50 gene and extending into the
IL13 promoter region, whereas rs20541 showed low levels of LD
with RAD50 SNPs (Figure S2). Thus, we cannot reliably
differentiate the specific source of the signal between RAD50 and
IL13 in our data. Functional studies are needed to assess whether
RAD50 is a true causal gene and to identify the causal genetic
variants modulating IgE levels in this region.
The identification and positive replication of the STAT6 locus,
which is located in one of the most frequently identified genomic
regions linked to atopy-related phenotypes [34], serves as positive
control for the experiment. Our results confirm previous candidate
studies which showed that genetic variants in the gene encoding
STAT6, a key regulatory element of the TH2 immune response,
contribute to the regulation of total serum IgE [35,36].
Other previously reported candidate genes for total IgE showed
no or only weak signals in our genome-wide scan (Tables S10 and
S11). However, it has to be considered that there are only very few
genes that have been associated in the first place to IgE such as
STAT6, whereas most reported candidate genes for total IgE were
investigated in asthma or eczema cohorts [10,11]. In addition,
there have been queries with regard to replication for many of the
genes reported. Thus, our data obtained in a population-based
and ethnically homogeneous sample (South German Caucasians)
are not readily comparable with previous candidate gene studies.
Furthermore some previously implicated variants were covered
insufficiently by the 500 k random SNP array (Table S10).
In summary, in this first GWAS on total IgE FCER1A was
identified and replicated as new susceptibility locus at which
common genetic variation influences serum IgE levels. In addition,
our data suggest that variants within the RAD50 gene might
represent additional factors within cytokine gene cluster on
chromosome 5q31, emphasizing the need for further investigations
in this intriguing region.
Methods
Subjects and Study Design
A detailed description of the GWAS population and the
replication samples is given in Text S1 and Table S1. In all studies
informed consent has been given, and all studies have been
approved by the local ethical committees. The participants were of
European origin.
KORA S3/F3 500 K and Replication Sample KORA S4
The study population for the GWAS (KORA S3/F3 500 K)
and the first replication cohort were recruited from the KORA S3
and S4 surveys. Both are independent population-based samples
from the general population living in the region of Augsburg,
Southern Germany, and were examined in 1994/95 (KORA S3)
and 1999/2001 (KORA S4). The standardized examinations
applied in both surveys have been described in detail elsewhere
[37]. In the KORA S3 study 4,856 subjects (participation rate
75%), and in KORA S4 in total 4,261 subjects have been
examined (participation rate 67%). 3,006 subjects participated in a
follow-up examination of S3 in 2004/05 (KORA F3). For KORA
S3/F3 500 K we selected 1,644 subjects of these participants in
the age range 25 to 69 years including 1,530 individuals with total
IgE level available. From KORA S4, DNA samples from 3,890
individuals with total IgE level were available. Total and specific
IgE antibodies to aeroallergens (S61) were measured using RAST
FEIA CAP system (Pharmacia, Freiburg, Germany). Specific
sensitization was defined as specific IgE levels $0.35KU/l (CAP
class .=1).
GINI and LISA Replication Samples
GINI (German Infant Nutritional Intervention Program) and
LISA (Influences of lifestyle-related factors on the immune system
and the development of allergies in childhood study) are two
ongoing population-based birth cohorts conducted in Germany. A
detailed description of screening and recruitment has been
provided elsewhere [38]. Briefly, the GINI birth cohort comprises
5,991 newborns, who were recruited between January 1996 and
June 1998 in 16 maternity wards in Wesel and Munich, Germany.
Children with a positive medical history of atopic disease were
invited to a randomized clinical trial with hydrolyzed formulae
[39]. The LISA birth cohort study includes 3,097 neonates who
were recruited between December 1997 and January 1999 in
Munich, Leipzig and Wesel, Germany. Blood samples were
collected from 1,962 (51%) and 1,193(50%) children from the
GINI and LISA study, respectively, at age 6. Total IgE was
determined by standardized methods with CAP-RAST FEIA
(Pharmacia Diagnostics, Freiburg, Germany).
ISAAC Replication Sample
Between 1995 and 1996, a cross sectional study was performed
in Munich and in Dresden, Germany as part of the International
Study of Asthma and Allergy in Childhood phase II (ISAAC II) to
assess the prevalence of asthma and allergies in all schoolchildren
attending 4
th class in both cities (age 9 to 11 years) [40]. Serum
measurements for total and specific IgE were performed according
to standardized procedures as previously described [40]. Allergic
sensitization was defined as positive prick test reaction to at least
one out of six common aeroallergens. Within the study population
Genome-Wide Association Study on Total IgE
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total IgE level available were included in this analysis (n=2,998).
KORA S3/F3 500 K Genotyping and Quality Control
Genotyping for KORA S3/F3 500 K was performed using
Affymetrix Gene Chip Human Mapping 500 K Array Set
consisting of two chips (Sty I and Nsp I). Genomic DNA was
hybridized in accordance with the manufacturer’s standard
recommendations. Genotypes were determined using BRLMM
clustering algorithm. We performed filtering of both conspicuous
individuals and single nucleotide polymorphisms (SNPs) to ensure
robustness of association analysis. Details on quality criteria are
described in Text S1 and Table S2.
SNP Selection for Replication and Fine-Mapping
The power of the replication was estimated for a difference in
log total IgE per allele of 0.2 and a nominal significance level of
0.05. The power to detect a true association was above 85% in
KORA S4, GINI and ISAAC; whereas in LISA it was about 55%.
No single SNPs in the GWAS reached genome-wide significance
using a Bonferroni threshold of 1.4610
27. To fine map the
replicated loci in KORA S4 we selected tagging SNPs and used
the pairwise tagging algorithm (r
2.0.8) implemented in HAPLO-
VIEW 3.3 (HapMap data release #22, March 2007, on NCBI
B36 assembly, dbSNP b126) and additionally selected putative
functional SNPs in FCER1A and RAD50.
SNP Genotyping and Quality Control in the Replication
Samples
In all replication samples genotyping of SNPs was realized with
the iPLEX (Sequenom San Diego, CA, USA) method by means of
matrix assisted laser desorption ionisation-time of flight mass
spectrometry method (MALDI-TOF MS, Mass Arraay, Seque-
nom, San Diego, CA, USA) according to the manufacturers
instructions. In KORA S4 for 7 of 84 replicated SNPs a deviation
from Hardy-Weinberg-Equilibrium was observed (P value,0.01).
In LISA, GINI and ISAAC all replicated SNPs were in HWE.
Details on genotyping are described in Text S1 and Table S4.
Mutational Analysis by Cycle Sequencing
FCER1A exons were amplified with intronic primers (Tables S5
and S6) and were directly sequenced using a BigDye Cycle
sequencing kit (Applied Biosystems). Genomic DNA (,30 ng) was
subjected to PCR amplification carried out in a 15 ml volume
containing 16 PCR Master Mix (Promega), 0.25 mM of each
forward and reverse primer under the following cycle conditions:
initial step at 95uC for 5 min, for 30 cycles at 95uC for 30 s, 58uC
(exon 1 62uC) for 30 s, and 72uC for 30 s; and final extension at
72uC for 5 min.
Statistical Analysis of Genetic Effects
In the KORA S3/F3 500 K sample possible population sub-
structures were analyzed (Text S1). Additive genetic models
assuming a trend per copy of the minor allele were used to specify
the dependency of logarithmic values of total IgE levels on genotype
categories. The result is a multiplicative model on the original scale
of total IgE with effects interpreted in percental changes. All models
were adjusted for gender and in the adult cohorts we adjusted
additionally for age. We used a linear regression algorithm
implemented in the statistical analysis system R (http://www.r-
project.org/) and SAS (Version 9.1.). To select significant SNPs in
the genome-wide screening and the replications we used conserva-
tive Bonferroni thresholds which corresponded to a nominal level of
0.05. Haplotype reconstruction and haplotype association analysis
was performed in the KORA S4 replication sample using the R-
library HaploStats that allows including all common haplotypes in the
linear regression and incorporating age and gender as covariates.
The most common haplotype served as reference. Details on
haplotype analysis are described in Text S1.
Gene Expression Analysis
Peripheral blood (2.5 ml) was drawn from individuals partici-
pating in the KORA study under fasting conditions. The blood
samples were collected between 10–12am directly in PAXgene
(TM) Blood RNA tubes (PreAnalytiX). The RNA extraction was
performed using the PAXgene Blood RNA Kit (Qiagen). RNA
and cRNA quality control was carried out using the Bioanalyzer
(Agilent) and quantification was done using Ribogreen (Invitro-
gen). 300–500 ng of RNA was reverse transcribed into cRNA and
biotin-UTP labeled using the Illumina TotalPrep RNA Amplifi-
cation Kit (Ambion). 1,500 ng of cRNA was hybridized to the
Illumina Human-6 v2 Expression BeadChip. Washing steps were
carried out in accordance with the Illumina technical note #
11226030 Rev. B. The raw data were exported from the Illumina
‘‘Beadstudio’’ Software to R. The data were converted into
logarithmic scores and normalized using the LOWESS method
[41]. The association between FCER1A gene expression (indepen-
dent variable) and IgE level (dependent variable) was computed
using the linear regression model adjusted for gender.
Supporting Information
Figure S1 Box plot comparing the total IgE levels for the
genotypes at rs2251746. The x axis represents the three genotype
groups: TT (major homozygote), CT (heterozygote) and CC
(minor homozygote). The y axis is the total IgE level on a
logarithmic scale. Plot was created in R using the box plot function
from the graphics package.
Found at: doi:10.1371/journal.pgen.1000166.s001 (0.38 MB TIF)
Figure S2 Patterns of pairwise LD between the SNPs at the
RAD50-IL13 locus.
Found at: doi:10.1371/journal.pgen.1000166.s002 (0.03 MB TIF)
Table S1 Description of study populations.
Found at: doi:10.1371/journal.pgen.1000166.s003 (0.05 MB
DOC)
Table S2 KORA S3/F3 500K SNP exclusion. Detailed
breakdown of SNPs that were monomorphic or did not pass
quality control and therefore did not enter analysis.
Found at: doi:10.1371/journal.pgen.1000166.s004 (0.04 MB
DOC)
Table S3 Details on the association analysis of SNPs selected for
replication (additive model).
Found at: doi:10.1371/journal.pgen.1000166.s005 (0.25 MB
DOC)
Table S4 Genotyping details on replication and fine-mapping
stages.
Found at: doi:10.1371/journal.pgen.1000166.s006 (0.15 MB
DOC)
Table S5 Primers used to amplify the exons of FCER1A.
Found at: doi:10.1371/journal.pgen.1000166.s007 (0.04 MB
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Table S6 Mutational analysis of FCER1A exons.
Found at: doi:10.1371/journal.pgen.1000166.s008 (0.04 MB
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levels in KORA S4. Results correspond to the single SNP analyses
where presence of A (rs2427837) and C (rs2251746) alleles at
respective positions were strongly associated.
Found at: doi:10.1371/journal.pgen.1000166.s009 (0.05 MB
DOC)
Table S8 Association analysis of FCERA1 and RAD50 variants
with AE in 562 German AE trios and with asthma in 638 UK
asthma cases and 633 controls.
Found at: doi:10.1371/journal.pgen.1000166.s010 (0.06 MB
DOC)
Table S9 Extended SNP analysis in the RAD50-IL13 region in
a subset of 526 children from the ISAAC replication cohort and
association with total IgE levels.
Found at: doi:10.1371/journal.pgen.1000166.s011 (0.05 MB
DOC)
Table S10 Genes that have been associated with total IgE
ordered by their chromosomal position.
Found at: doi:10.1371/journal.pgen.1000166.s012 (0.16 MB
DOC)
Table S11 Affymetrix SNPs in selected candidate genes for total
IgE, which yielded a nominal p-value ,0.05 in the GWAS. Genes
are ordered by their chromosomal position.
Found at: doi:10.1371/journal.pgen.1000166.s013 (0.14 MB
DOC)
Text S1 Supplementary information.
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